Gene search

Sequence information

Select Gene Cds Cds_length GC_content Pep Pep_length
Hepe02g2817 ATGGAAGGGGAAATCGATCGATTTCTTAAACGGTGTTTATTGTACCTTATAGCTATGTGCTTAAGCTTAACAATGGTGGGTTCATTAGTTGCTGCTTCTCTATCTCCTGATGGAGAAGCGCTTCTCTCTCTGATTGCTTCTGCTGATTCTTCTTCCTCTGTTTTTGCTTCTTGGAATCCATCTAGCCAAAACCCTTGTGCTTGGGAAGGAATCACTTGTTCTCCTCAGAATAGAGTTATTTCATTGTCTCTCCCGAAAACATTTCTAAACCTTTCGTTTTTGCCTCCTGAGTTGTCTTCTTTATCTTCTCTGCAACTTCTTAATCTCTCTTCCACTAATGTATCTGGGTCAATCCCTCCTTCTTTTGGCCTACTCACTCATCTTCGCCTGTTGGATCTTTCATCAAACAATCTCTATGGCTCGATTCCTCCTCAGCTTGGTTCTCTTTCTTCACTTCAATTCCTTTTCCTGAATTCCAATAGACTGTCTGGTAAGATTCCTGCGCAGCTTGCTAATCTGACTTCTCTGCAAAGTCTTTGCCTCCAAGATAATCTGTTTAATGGCTCCATACCATCACAGTTTGGTTCTTTGCTATCCCTTCAAGAGATGCGAATCGGAGGGAATCCGTATCTTTCAGGAGAGATTCCGCCACAGATAGGGTTGCTTACTAATCTCACTACGTTTGGGGCAGCGGCTACCGCACTTTCCGGGGCTATACCGTCTACATTTGGGAGTCTTATCAGCCTCCAAACTTTGTCGCTTTATGATACTGAGATGTCTGGTTCAATACCTCCTGAGTTGGGACTTTGTTCTGAGCTAAGGGATTTGTATTTACACATGAACAAGCTCACTGGTAATATGCCTCCTCAGCTGGGGAGGTTGCAGAAGCTTACTAGTTTGTTTCTATGGGGTAATGCTATATCGGGGGCGATACCGTCTGAAATTTCGAATTGTTCGGCTCTTGTTGTTTTTGATGCTTCGGATAATGATCTTTCTGGTGAAATCCCAAGTGATTTAGGGAAGTTGGTTGTTCTTGAACAGTTTCATATATCTGACAATTCAATCTCGGGTTCGATACCATGGCAGTTGGGCAACTGCACAAGCTTAACTGCCCTTCAGCTTGATAATAATCAATTATCAGGTGTAATTCCATCACAACTTGGCAATTTGAAATCCCTGCAAAGTTTTTTCTTATGGGGCAACTCTGTATCAGGAACCATACCATCTTCCTTTGGCAACTGCACTGAGTTATATGCTCTTGATCTTTCAAGAAACAAGCTCACTGGAATAATCCCAGAAGAAATTTTCAGCTTGAAGAAGTTGAGCAAGCTTTTGCTCCTTGGAAATTCTTTATCTGGCGGGTTGCCACGAAGTGTCGCGAATTGTCAATCATTGGTGAGGTTGAGGCTTGGAGAAAACCAGCTTTCAGGCCAGATTCCGAAGGAGGTAGGCCAGTTGCAAAATCTTGTCTTTCTTGACTTGTATATGAATCATTTTTCGGGTGGTCTTCCGTCTGAGATTGCTAATATTACAGTTCTTGAGCTACTTGATGTGCATAACAATTATATAACTGGGGAAATTCCTCCCCAGCTTGGGGAGTTGGTGAACTTGGAGCAGCTCGATCTCAGTAGAAACAGCTTCACTGGTGAAATTCCTCAGAGCTTTGGAAACTTCAGTTATTTGAATAAACTTATTCTCAACAATAATCTACTGACAGGGTCAATTCCAAAGTCCATTAAGAACCTGGAGAAACTAACTTTACTTGATTTGAGTTACAACAGTCTCTCTGGCACGATACCACCAGAAATTGGTTACATGAAGAGCTTGTCAATCAGTCTGGACTTGAGCTCGAACGGGATAACCGGAGAAATTCCCGAGACGATGTCCAGTTTGACACAGTTACAATCACTTGATCTTTCCCATAACATGCTTTATGGAAATATTAAAGTGTTGGGTCTCTTGACTAGCCTCACATCTCTTAATATCTCCTACAACAATTTCTCAGGTCCCATGCCCGTAACACCATTTTTTAGAACCCTATCAGAAGATGCATATTATCAAAACCTGAATCTTTGTGGATCACTTGATGGATTTACTTGTTCCTCGAGTTTAATGCGAAGAAATAGCTTAAAGTCTGCAAAAGCTGCTGCTTTAATCTCCATCATTCTTGTTGCAGTTGTCATCCTAGTTTTTGCTTTGTGGATGCTAGTTTCACGAAATCGTAAGTACATGGCAGAGAAATATTCTGGGACGTTGTCCTCTGCATCCGCTGCTGAGGATTTCTCTTATCCATGGACCTTCATCCCATTTCAGAAGCTCAATTTTAGCATAGATAACATCTTGGAATCCATGAAAGAAGAAAATATAATTGGAAAAGGTTGGTCTGGGGTTGTTTATAAAGCAGATATGCCAAATGGTGAATTAGTTGCTGTGAAGAAACTGTGGAAAACAAAACAAGATGAAGAAGCAGTTGACTCGTGCGCTGCAGAGATCCAAATTCTCGGGCATATTCGACATCGTAACATAGTGAAGCTCATAGGTTATTGTTCCAATAGAAGTGTCAAGATACTTCTCTACAACTATATTTCAAATGGTAATCTGCAACAACTCTTGGAAGGAAACAGAAATTTGGACTGGGAGACTAGGTATAAGATCGCGGTCGGGACGGCCCAGGGTCTGGCTTATCTTCATCATGATTGTGTGCCTGCAATTCTTCACAGAGATGTCAAGTGCAACAACATACTTCTAGACTCAAGGTTTGAAGCTTATCTAGCAGATTTTGGCCTGGCAAAGTTGATGAACACTCCAAATTATCATCATGCAATTTCGAGAGTAGCCGGGTCTTATGGTTATATCGCGCCAGAATACGGATATACCATGAATATAACCGAGAAGAGTGATGTCTATAGCTATGGAGTCGTTCTGCTAGAGATACTAAGTGGTCGTAGCGCAATTGAGACACAACTTGGAGATGGCATTCACATTGTTGAGTGGGTGAAGAAGAAGATGGCAAGCTTCGAACCGGCCATATCGATACTCGACACAAAGCTGCAGAGTTTACCAGATCAGATGGTGCAAGAAATGCTTCAAACATTAGGTATAGCAATGTTTTGTGTGAACTCCTCTCCAGTAGAAAGGCCAACAATGAAGGAAGTGGTAGCATTGTTGATGGAGGTGAAAAGTCCTCCAGAAGAATGGGGCAAAACCTCCCAACCTTTAATAAAGCAGTCCTCAAATTTAAGTTGA 3246 41.77 MEGEIDRFLKRCLLYLIAMCLSLTMVGSLVAASLSPDGEALLSLIASADSSSSVFASWNPSSQNPCAWEGITCSPQNRVISLSLPKTFLNLSFLPPELSSLSSLQLLNLSSTNVSGSIPPSFGLLTHLRLLDLSSNNLYGSIPPQLGSLSSLQFLFLNSNRLSGKIPAQLANLTSLQSLCLQDNLFNGSIPSQFGSLLSLQEMRIGGNPYLSGEIPPQIGLLTNLTTFGAAATALSGAIPSTFGSLISLQTLSLYDTEMSGSIPPELGLCSELRDLYLHMNKLTGNMPPQLGRLQKLTSLFLWGNAISGAIPSEISNCSALVVFDASDNDLSGEIPSDLGKLVVLEQFHISDNSISGSIPWQLGNCTSLTALQLDNNQLSGVIPSQLGNLKSLQSFFLWGNSVSGTIPSSFGNCTELYALDLSRNKLTGIIPEEIFSLKKLSKLLLLGNSLSGGLPRSVANCQSLVRLRLGENQLSGQIPKEVGQLQNLVFLDLYMNHFSGGLPSEIANITVLELLDVHNNYITGEIPPQLGELVNLEQLDLSRNSFTGEIPQSFGNFSYLNKLILNNNLLTGSIPKSIKNLEKLTLLDLSYNSLSGTIPPEIGYMKSLSISLDLSSNGITGEIPETMSSLTQLQSLDLSHNMLYGNIKVLGLLTSLTSLNISYNNFSGPMPVTPFFRTLSEDAYYQNLNLCGSLDGFTCSSSLMRRNSLKSAKAAALISIILVAVVILVFALWMLVSRNRKYMAEKYSGTLSSASAAEDFSYPWTFIPFQKLNFSIDNILESMKEENIIGKGWSGVVYKADMPNGELVAVKKLWKTKQDEEAVDSCAAEIQILGHIRHRNIVKLIGYCSNRSVKILLYNYISNGNLQQLLEGNRNLDWETRYKIAVGTAQGLAYLHHDCVPAILHRDVKCNNILLDSRFEAYLADFGLAKLMNTPNYHHAISRVAGSYGYIAPEYGYTMNITEKSDVYSYGVVLLEILSGRSAIETQLGDGIHIVEWVKKKMASFEPAISILDTKLQSLPDQMVQEMLQTLGIAMFCVNSSPVERPTMKEVVALLMEVKSPPEEWGKTSQPLIKQSSNLS 1081
       

Gff information

Chromosome Start End Strand Old_gene Gene Num
2 77276154 77279664 + Hsped.02g28170.1 Hepe02g2817 564318
       

Annotation information

Select Seq ID Length Analysis Description Start End IPR GO
Hepe02g2817 1081 SMART LRR_typ_2 173 197 IPR003591 -
Hepe02g2817 1081 SMART LRR_typ_2 366 390 IPR003591 -
Hepe02g2817 1081 SMART LRR_typ_2 414 438 IPR003591 -
Hepe02g2817 1081 SMART LRR_typ_2 294 318 IPR003591 -
Hepe02g2817 1081 SMART LRR_typ_2 631 656 IPR003591 -
Hepe02g2817 1081 SMART LRR_typ_2 582 606 IPR003591 -
Hepe02g2817 1081 SMART LRR_typ_2 125 149 IPR003591 -
Hepe02g2817 1081 SMART LRR_typ_2 534 557 IPR003591 -
Hepe02g2817 1081 Gene3D Transferase(Phosphotransferase) domain 1 862 1071 - -
Hepe02g2817 1081 ProSitePatterns Serine/Threonine protein kinases active-site signature. 904 916 IPR008271 GO:0004672(InterPro)|GO:0006468(InterPro)
Hepe02g2817 1081 ProSiteProfiles Protein kinase domain profile. 784 1074 IPR000719 GO:0004672(InterPro)|GO:0005524(InterPro)|GO:0006468(InterPro)
Hepe02g2817 1081 Gene3D Ribonuclease Inhibitor 191 282 IPR032675 -
Hepe02g2817 1081 Gene3D Ribonuclease Inhibitor 283 380 IPR032675 -
Hepe02g2817 1081 SUPERFAMILY Protein kinase-like (PK-like) 769 1057 IPR011009 -
Hepe02g2817 1081 FunFam LRR receptor-like serine/threonine-protein kinase GSO1 511 704 - -
Hepe02g2817 1081 Gene3D Phosphorylase Kinase; domain 1 753 861 - -
Hepe02g2817 1081 Gene3D Ribonuclease Inhibitor 381 480 IPR032675 -
Hepe02g2817 1081 FunFam Leucine-rich repeat receptor-like serine/threonine-protein kinase BAM3 440 510 - -
Hepe02g2817 1081 FunFam Probable LRR receptor-like serine/threonine-protein kinase At1g34110 34 193 - -
Hepe02g2817 1081 PANTHER OS04G0122200 PROTEIN 49 208 IPR051809 -
Hepe02g2817 1081 Gene3D Ribonuclease Inhibitor 576 701 IPR032675 -
Hepe02g2817 1081 Gene3D Ribonuclease Inhibitor 481 575 IPR032675 -
Hepe02g2817 1081 Gene3D Ribonuclease Inhibitor 35 190 IPR032675 -
Hepe02g2817 1081 Pfam Leucine Rich Repeat 345 366 IPR001611 GO:0005515(InterPro)
Hepe02g2817 1081 Pfam Leucine Rich Repeat 612 631 IPR001611 GO:0005515(InterPro)
Hepe02g2817 1081 Pfam Leucine Rich Repeat 151 173 IPR001611 GO:0005515(InterPro)
Hepe02g2817 1081 Pfam Leucine Rich Repeat 127 149 IPR001611 GO:0005515(InterPro)
Hepe02g2817 1081 Pfam Leucine Rich Repeat 656 672 IPR001611 GO:0005515(InterPro)
Hepe02g2817 1081 Pfam Leucine Rich Repeat 175 197 IPR001611 GO:0005515(InterPro)
Hepe02g2817 1081 Pfam Leucine Rich Repeat 368 390 IPR001611 GO:0005515(InterPro)
Hepe02g2817 1081 Pfam Leucine Rich Repeat 513 534 IPR001611 GO:0005515(InterPro)
Hepe02g2817 1081 Pfam Leucine Rich Repeat 103 124 IPR001611 GO:0005515(InterPro)
Hepe02g2817 1081 Pfam Leucine Rich Repeat 321 342 IPR001611 GO:0005515(InterPro)
Hepe02g2817 1081 Pfam Leucine Rich Repeat 296 318 IPR001611 GO:0005515(InterPro)
Hepe02g2817 1081 Pfam Leucine Rich Repeat 488 509 IPR001611 GO:0005515(InterPro)
Hepe02g2817 1081 FunFam Putative LRR receptor-like serine/threonine-protein kinase 769 861 - -
Hepe02g2817 1081 ProSiteProfiles Leucine-rich repeat profile. 633 655 IPR001611 GO:0005515(InterPro)
Hepe02g2817 1081 SMART serkin_6 784 1060 IPR000719 GO:0004672(InterPro)|GO:0005524(InterPro)|GO:0006468(InterPro)
Hepe02g2817 1081 PRINTS Leucine-rich repeat signature 585 598 - -
Hepe02g2817 1081 PRINTS Leucine-rich repeat signature 631 644 - -
Hepe02g2817 1081 Pfam Protein kinase domain 786 1053 IPR000719 GO:0004672(InterPro)|GO:0005524(InterPro)|GO:0006468(InterPro)
Hepe02g2817 1081 Pfam Leucine rich repeat 392 451 IPR001611 GO:0005515(InterPro)
Hepe02g2817 1081 Pfam Leucine rich repeat 536 595 IPR001611 GO:0005515(InterPro)
Hepe02g2817 1081 SUPERFAMILY L domain-like 60 404 - -
Hepe02g2817 1081 SUPERFAMILY L domain-like 383 705 - -
Hepe02g2817 1081 FunFam LRR receptor-like serine/threonine-protein kinase RCH1 862 1074 - -
Hepe02g2817 1081 FunFam LRR receptor-like serine/threonine-protein kinase RCH1 209 432 - -
Hepe02g2817 1081 Pfam Leucine rich repeat N-terminal domain 35 74 IPR013210 -
Hepe02g2817 1081 ProSitePatterns Protein kinases ATP-binding region signature. 790 813 IPR017441 GO:0005524(InterPro)
       

Duplication type information

Select Gene1 Location1 Gene2 Location2 E-value Duplicated-type
Hepe02g2817 Hepe-Chr2:77276154 Hepe03g0339 Hepe-Chr3:4763061 5.83e-105 dispersed
Hepe07g0260 Hepe-Chr7:2563724 Hepe02g2817 Hepe-Chr2:77276154 1.32e-55 dispersed
Hepe02g2817 Hepe-Chr2:77276154 Hepe04g1362 Hepe-Chr4:69258205 2.52e-90 transposed
       

Transcription factors information

Select Gene Hmm_acc Hmm_name Score E-value Regulatory Factors Family
72604 PF00069 Pkinase 3.80E-46 CL0016 Hepe PK
       

Pathway information

Select Query KO Definition Second KO KEGG Genes ID GHOSTX Score
Hepe02g2817 - - - 0.0